Use of rtl8-deficient cells to produce biocompatible, peg10-derived virus-like particles (vlp)
AssigneeThe Regents of the University of Colorado, a body corporate
InventorsAlexandra Whiteley, William Campodonico-Burnett, Aaron Whiteley
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel systems, methods, and compositions for increasing the production of virus-like particles (VLPs) in a cell. In particular, the invention includes disrupting the activity or expression of RTL8 and/or UBQLN2 in the cell, which causes an increase in PEG10 VLP formation.
Claims14
A method of increasing production of virus-like particles (VLPs) in a cell, comprising the step of disrupting the activity or expression of RTL8, UBQLN2, or RTL8 and UBOLN2 in the cell, wherein said disruption causes an increase in PEG10 VLP formation.
13-56. (canceled)
Dependencies are inferred from the claim text.